Association of decreased C1q/tumor necrosis factorrelated protein-5 levels with metabolic and hormonal disturbance in polycystic ovary syndrome

Journal Title: UNKNOWN - Year 2019, Vol 20, Issue 2

Abstract

Objective: C1q/tumor necrosis factor-related protein-5 (CTRP5) is a novel peptide hormone involved in the metabolism of energy regulation. Polycystic ovary syndrome (PCOS), which is a reproductive and metabolic disorder, is associated with insulin resistance. The aim of the current study was to compare circulating levels of CTRP5 in women with and without PCOS and to investigate possible associations between CTRP5 and metabolic-hormonal parameters. Material and Methods: The present cross-sectional study contained 80 women with PCOS and 80 age and body mass index-matched women without PCOS. Circulating levels of CTRP5 were calculated using an enzyme-linked immunosorbent assay. We also measured hormonal and metabolic parameters. Results: Patients with PCOS had lower levels of circulating CTRP5 compared with women without PCOS (6.90±2.64 vs 11.73±3.66 ng/mL, p<0.001). CTRP5 was negatively correlated with insulin resistance, free-androgen index, and body mass index in both the PCOS and control groups. Moreover, patients with PCOS who had insulin resistance showed lower circulating CTRP5 levels compared with those without insulin resistance. In both the control and PCOS groups, overweight subjects had lower circulating levels of CTRP5 compared with participants of normal weight. Logistic regression analyses indicated that subjects in the lowest tertile for CTRP5 level had higher risk for PCOS compared with those in the highest tertile of CTRP5. Conclusion: Decreased circulating levels of CTRP5 were associated with higher risk of PCOS, as well as having metabolic disturbance among women with PCOS.

Authors and Affiliations

Mehmet Çalan, Murat Alan, Pınar Alarslan, Gökçen Ünal Kocabaş, Giray Bozkaya, Ahmet Çağdaş Acara, Behnaz Aslanipour, Özge Fenercioğlu, Ahmet Murat Işıl, Aslı Güler

Keywords

Related Articles

Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome

Herein, we aimed to review, report, and discuss the role of cystoscopy and clinical phenotyping in interstitial cystitis/bladder pain syndrome (IC/BPS). For this purpose; a comprehensive nonsystematic review of the relev...

Clinical characteristics and location of lesions in patients with deep infiltrating endometriosis using the revised Enzian classification

Objective: To describe the clinical characteristics and location of lesions in patients with deeply infiltrating endometriosis using the revised Enzian (rEnzian) classification. Material and Methods: The clinical records...

Platelet-to-lymphocyte ratio: A new inflammatory marker for the diagnosis of preterm premature rupture of membranes

Objective: Preterm premature rupture of membranes (PPROM) is closely related with maternal and fetal complications. Therefore, early diagnosis is extremely important to provide maternal and fetal well-being. Many inflamm...

Clinical predictors of successful vaginal myomectomy for prolapsed pedunculated uterine leiomyoma

Objective: Uterine leiomyomas are the most common pelvic tumor in women. The calculated prevalence of prolapsed pedunculated leiomyoma was 2.5% in patients who underwent surgery. Although vaginal removal is safe and effe...

Fertility preservation in Turkey: a global look for nationwide strategy development

As the reproductive technology advanced along with the improved outcome in cancer treatment demands implementing new fertility preservation, developing algorithms on fertility preservation requires tailoring for each soc...

Download PDF file
  • EP ID EP582033
  • DOI 10.4274/jtgga.galenos.2018.2018.0027
  • Views 48
  • Downloads 0

How To Cite

Mehmet Çalan, Murat Alan, Pınar Alarslan, Gökçen Ünal Kocabaş, Giray Bozkaya, Ahmet Çağdaş Acara, Behnaz Aslanipour, Özge Fenercioğlu, Ahmet Murat Işıl, Aslı Güler (2019). Association of decreased C1q/tumor necrosis factorrelated protein-5 levels with metabolic and hormonal disturbance in polycystic ovary syndrome. UNKNOWN, 20(2), 89-96. https://europub.co.uk/articles/-A-582033